Use of a fluoropolymer-based paclitaxel-eluting stent for arteriovenous graft outflow vein stenosis in hemodialysis patients

Use of a fluoropolymer-based paclitaxel-eluting stent for arteriovenous graft outflow vein stenosis in hemodialysis patients

We implanted a fluoropolymer-based paclitaxel-eluting stent (FP-PES) in four hemodialysis patients with refractory outflow venous stenosis of their arteriovenous graft. The mean observation period after FP-PES implantation was 11.5 ± 4.7 months (range, 7.0-18.0 months). After FP-PES implantation, th...

Full description

Bibliographic Details
Main Authors: Yuki Matsuoka, MD, MBA, Osamu Iida, MD, Kotaro Suemitsu, MD, PhD, Kanako Oka, MD, Naomi Ota, MD, Masaaki Izumi, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Journal of Vascular Surgery Cases and Innovative Techniques
Subjects:
Arteriovenous shunt
Drug-eluting stents
Hemodialysis
Paclitaxel
Stenosis
Online Access:http://www.sciencedirect.com/science/article/pii/S246842872100054X

Internet

http://www.sciencedirect.com/science/article/pii/S246842872100054X

Similar Items